Skip to main content

Advertisement

SpringerLink
Log in

Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is one of the most common autoimmune peripheral neuropathies in adults. Membranous nephropathy (MN), focal segmental glomerulosclerosis (FSGS), and other nephropathy have been reported in CIDP patients and are possibly correlated to CIDP pathogenesis. This study reviewed the previously described cases of patients with CIDP and nephropathy in order to provide comprehensive evidence on the diagnosis and treatment regarding CIDP patients in the context of renal diseases.

Method

We reviewed our database to identify patients with CIDP and nephropathy. Online database including PubMed, EMBASE, and OVID were searched for relevant cases.

Results

We identified a total of 18 cases with CIDP and nephropathy, including 2 cases from our database and 16 ones from online searching. A predominance of male was observed [14 (77.8%)] with the mean age of 53.3 (standard deviation, SD: 16.6) years old. Almost all patients complained paresthesia in distal limbs (94.4%), except one only presented weakness of four extremities. Corticosteroids were prescribed for 14 (77.8%) patients, and 10 showed responsiveness. Three patients experienced relapses during the gradual tapering of steroids.

Conclusion

The same immune-mediated pathogenesis may be involved in CIDP and concomitant nephropathy. Male and sensory-predominant CIDP are red flags for complications of renal diseases in CIDP patients. Corticosteroids remain the first-line treatment for CIDP when complicated with renal diseases. Slower tapering or long-term maintenance of steroids may be beneficial for the prognosis of patients with CIDP and nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

All data analyzed during this study are included in published articles.

References

  1. Peltier AC, Donofrio PD (2012) Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside. Semin Neurol 32(3):187–195

    Article  Google Scholar 

  2. Reynolds J, Sachs G, Stavros K (2013) Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): clinical features, diagnosis, and current treatment strategies. R I Med J 2016 Dec 1 99(12):32–35

  3. Van den Bergh PYK et al (2021) European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. Eur J Neurol 28(11):3556–3583

    Article  Google Scholar 

  4. Broers MC et al (2019) Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology 52(3–4):161–172

    Article  Google Scholar 

  5. Reinhard L, Stahl RAK, Hoxha E (2020) Is primary membranous nephropathy a complement mediated disease? Mol Immunol 128:195–204

    Article  CAS  Google Scholar 

  6. Sinico RA et al (2016) Immunology of membranous nephropathy: from animal models to humans. Clin Exp Immunol 183(2):157–165

    Article  CAS  Google Scholar 

  7. Witte AS, Burke JF (1987) Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy. Neurology 37(2):342–345

    Article  CAS  Google Scholar 

  8. Donadio JV Jr, Burgess JH, Holley KE (1977) Membranous lupus nephropathy: a clinicopathologic study. Med (Baltimore) 56(6):527–36

    Article  Google Scholar 

  9. Chen R et al (2021) Sjögren’s syndrome complicated with membranous nephropathy, a cause or coincidence? Int J Rheum Dis 24(8):1086–1094

    Article  CAS  Google Scholar 

  10. Julio PR et al (2021) Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus. Semin Arthritis Rheum 51(1):158–165

    Article  CAS  Google Scholar 

  11. Seeliger T et al (2019) Neuro-Sjögren: peripheral neuropathy with limb weakness in Sjögren’s syndrome. Front Immunol 10:1600

    Article  CAS  Google Scholar 

  12. Alpaydın Baslo S et al (2021) CIDP and membranous nephropathy: a case with limited electrophysiological findings and a rare association. Neurol Sci 42(1):367–371

    Article  Google Scholar 

  13. Girolami F et al (2010) Coincident chronic inflammatory demyelinating polyneuropathy and focal segmental glomerulosclerosis: a common autoimmunity? Clin Exp Nephrol 14(3):294–295

    Article  Google Scholar 

  14. Souayah N et al (2008) Relapsing Guillain Barré Syndrome and nephrotic syndrome secondary to focal segmental glomerulosclerosis. J Neurol Sci 270(1–2):184–188

    Article  Google Scholar 

  15. Lucchetta M et al (2015) Long-term plasma exchange in pediatric CIDP. J Clin Apher 30(6):364–366

    Article  Google Scholar 

  16. Nishida Y et al (1998) Renal failure due to IgA (Berger) nephropathy with inflammatory demyelinating polyradiculoneuropathy. Nephron 80(1):123–124

    Article  CAS  Google Scholar 

  17. Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097

    Article  Google Scholar 

  18. Bukhari S et al (2020) Anti-neurofascin-associated nephrotic-range proteinuria in chronic inflammatory demyelinating polyneuropathy. Kidney Med 2(6):797–800

    Article  Google Scholar 

  19. Taieb G et al (2019) “Neuro-renal syndrome” related to anti-contactin-1 antibodies. Muscle Nerve 59(3):E19-e21

    Article  Google Scholar 

  20. Bolz S et al (2018) CIDP, myasthenia gravis, and membranous glomerulonephritis - three autoimmune disorders in one patient: a case report. BMC Neurol 18(1):113

    Article  Google Scholar 

  21. Hashimoto Y et al (2018) Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey. Front Neurol 9:997

    Article  Google Scholar 

  22. Quek AM et al (2014) Acute-onset chronic inflammatory demyelinating polyneuropathy with focal segmental glomerulosclerosis. J Neurol Sci 341(1–2):139–143

    Article  Google Scholar 

  23. Smyth S, Menkes DL (2008) Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning the autoimmunity hypothesis. Muscle Nerve 37(1):130–135

    Article  Google Scholar 

  24. Chen KH, Chang CT, Hung CC (2006) Glomerulonephritis associated with chronic inflammatory demyelinating polyneuropathy. Ren Fail 28(3):255–259

    Article  Google Scholar 

  25. Emsley HC, Molloy J (2002) Inflammatory demyelinating polyradiculoneuropathy associated with membranous glomerulonephritis and thrombocytopaenia. Clin Neurol Neurosurg 105(1):23–26

    Article  Google Scholar 

  26. Wu AD, Russell JA, Bouthout BA (2001) Chronic inflammatory demyelinating polyneuropathy and membranous glomerulonephropathy: report of two cases. J Clin Neuromuscul Dis 3(2):70–74

    Article  CAS  Google Scholar 

  27. Henderson RD et al (2000) Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation. J Clin Neurosci 7(2):148–149

    Article  CAS  Google Scholar 

  28. Mobbs RJ, Tuck RR, Hurley B (2000) Chronic inflammatory demyelinating polyneuropathy associated with membranous glomerulonephritis: case report. J Clin Neurosci 7(5):454–455

    Article  CAS  Google Scholar 

  29. Olbricht CJ et al (1993) Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature. Nephron 64(1):139–141

    Article  CAS  Google Scholar 

  30. McGrogan A, Franssen CF, de Vries CS (2011) The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 26(2):414–430

    Article  Google Scholar 

  31. Camargo CRS, Schoueri JHM, Alves BDCA, Veiga GRLD, Fonseca FLA, Bacci MR (1992) Uremic neuropathy: an overview of the current literature. Rev Assoc Med Bras 2019 Mar 65(3):469–474. https://doi.org/10.1590/1806-9282.65.3.469

  32. Couser WG (2017) Primary membranous nephropathy. Clin J Am Soc Nephrol 12(6):983–997

    Article  CAS  Google Scholar 

  33. Rosenberg AZ, Kopp JB (2017) Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 12(3):502–517

    Article  CAS  Google Scholar 

  34. Floege J, Amann K (2016) Primary glomerulonephritides. Lancet 387(10032):2036–2048

    Article  Google Scholar 

  35. Gras V, Andréjak M, Decocq G (1999) Acute renal failure associated with intravenous immunoglobulins. Pharmacoepidemiol Drug Saf 8(Suppl 1):S73–S78

    Article  Google Scholar 

  36. Malyszko J et al (2017) Nephrotoxicity of anticancer treatment. Nephrol Dial Transplant 32(6):924–936

    CAS  PubMed  Google Scholar 

  37. van de Logt AE et al (2019) The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int 96(6):1292–1302

    Article  Google Scholar 

  38. Panjwani M, Truong LD, Eknoyan G (1996) Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. Am J Kidney Dis 27(2):279–283

    Article  CAS  Google Scholar 

  39. Rezania K, Gundogdu B, Soliven B (2004) Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Front Biosci 9:939–45

    Article  CAS  Google Scholar 

  40. Reid RA et al (1994) Identification and characterization of the human cell adhesion molecule contactin. Brain Res Mol Brain Res 21(1–2):1–8

    Article  CAS  Google Scholar 

  41. Filippone EJ (2014) Idiopathic membranous nephropathy and IgG4: an interesting relationship. Clin Nephrol 82(1):7–15

    PubMed  Google Scholar 

  42. Cortese A et al (2020) Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol Neuroinflamm 7:1

    Article  Google Scholar 

  43. Santoro D, Debiec H, Longhitano E, Torreggiani M, Barreca A, Vegezzi E, Mazzeo A, Russo M, Piccoli GB, Toscano A, Ronco P (2021) Contactin 1, a potential new antigen target in membranous nephropathy: a case report. Am J Kidney Dis 2021 Nov 8:S0272–6386(21)00950–1. https://doi.org/10.1053/j.ajkd.2021.08.025

Download references

Acknowledgements

Authors would like to thank all the authors of the original articles.

Funding

This study has been supported by the CAMS Innovation Fund for Medical Sciences (CIFMS 2021-I2M-1–003) and the Beijing Natural Science Foundation (7202158).

Author information

Authors and Affiliations

  1. Department of Neurology, Peking Union Medical College Hospital, Beijing, 100730, China

    Nan Hu, Jingwen Niu & Mingsheng Liu

  2. Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China

    Mingsheng Liu

Authors
  1. Nan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingwen Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mingsheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mingsheng Liu.

Ethics declarations

Ethical approval and consent to participate.

Ethical approval and consent to participate were not necessary for this review.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 22 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, N., Niu, J. & Liu, M. Chronic inflammatory demyelinating polyradiculoneuropathy concomitant with nephropathy. Neurol Sci 43, 5885–5898 (2022). https://doi.org/10.1007/s10072-022-06215-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-06215-4

Keywords

Search

Navigation